These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 27464721)

  • 1. Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.
    Strazielle N; Ghersi-Egea JF
    Curr Pharm Des; 2016; 22(35):5463-5476. PubMed ID: 27464721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
    Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.
    Strazielle N; Ghersi-Egea JF
    Mol Pharm; 2013 May; 10(5):1473-91. PubMed ID: 23298398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin transport at the blood--cerebrospinal fluid barrier using the perfused sheep choroid plexus model.
    Thomas SA; Preston JE; Wilson MR; Farrell CL; Segal MB
    Brain Res; 2001 Mar; 895(1-2):283-90. PubMed ID: 11259792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
    Strazielle N; Khuth ST; Ghersi-Egea JF
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1717-40. PubMed ID: 15381331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively.
    Johanson C; Johanson N
    CNS Neurol Disord Drug Targets; 2016; 15(9):1151-1180. PubMed ID: 27633784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF, blood-brain barrier, and brain drug delivery.
    Pardridge WM
    Expert Opin Drug Deliv; 2016 Jul; 13(7):963-75. PubMed ID: 27020469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain, blood-cerebrospinal fluid and cerebrospinal fluid-brain barriers in a marsupial (Macropus eugenii) during development.
    Dziegielewska KM; Hinds LA; Møllgård K; Reynolds ML; Saunders NR
    J Physiol; 1988 Sep; 403():367-88. PubMed ID: 3075668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. I. Choroid plexus and the blood-cerebrospinal fluid barrier.
    Balin BJ; Broadwell RD
    J Neurocytol; 1988 Dec; 17(6):809-26. PubMed ID: 3230399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The choroid plexus-cerebrospinal fluid system: from development to aging.
    Redzic ZB; Preston JE; Duncan JA; Chodobski A; Szmydynger-Chodobska J
    Curr Top Dev Biol; 2005; 71():1-52. PubMed ID: 16344101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.
    Johanson CE; Duncan JA; Stopa EG; Baird A
    Pharm Res; 2005 Jul; 22(7):1011-37. PubMed ID: 16028003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease.
    Ghersi-Egea JF; Strazielle N; Catala M; Silva-Vargas V; Doetsch F; Engelhardt B
    Acta Neuropathol; 2018 Mar; 135(3):337-361. PubMed ID: 29368213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers].
    Suzuki H; Sugiyama Y
    Yakugaku Zasshi; 1994 Dec; 114(12):950-71. PubMed ID: 7869236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.
    Baird A; Eliceiri BP; Gonzalez AM; Johanson CE; Leadbeater W; Stopa EG
    Methods Mol Biol; 2011; 686():483-98. PubMed ID: 21082389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.
    Shen DD; Artru AA; Adkison KK
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1825-57. PubMed ID: 15381336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus.
    Ghersi-Egea JF; Strazielle N
    Microsc Res Tech; 2001 Jan; 52(1):83-8. PubMed ID: 11135451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide and peptide analog transport systems at the blood-CSF barrier.
    Smith DE; Johanson CE; Keep RF
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1765-91. PubMed ID: 15381333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
    Engelhardt B; Sorokin L
    Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Lymphocytes Traffic into the Brain across the Blood-CSF Barrier: Evidence Using a Reconstituted Choroid Plexus Epithelium.
    Strazielle N; Creidy R; Malcus C; Boucraut J; Ghersi-Egea JF
    PLoS One; 2016; 11(3):e0150945. PubMed ID: 26942913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topotecan central nervous system penetration is altered by a tyrosine kinase inhibitor.
    Zhuang Y; Fraga CH; Hubbard KE; Hagedorn N; Panetta JC; Waters CM; Stewart CF
    Cancer Res; 2006 Dec; 66(23):11305-13. PubMed ID: 17145877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.